Education
About Us
Working with TipRanks
Follow Us
Bioceres Crop Solutions (BIOX)
NASDAQ:BIOX
BIOX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.60 - $10.19
Previous CloseN/A
Volume111.91K
Average Volume (3M)263.26K
Market Cap
$169.95M
Enterprise Value$566.38M
Total Cash (Recent Filing)$39.35M
Total Debt (Recent Filing)$273.30M
Price to Earnings (P/E)193.5
Beta0.58
Next Earnings
Sep 09, 2025EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding62,710,846
10 Day Avg. Volume404,442
30 Day Avg. Volume263,259
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap3.33
Enterprise Value/Revenue1.48
Enterprise Value/Gross Profit3.71
Enterprise Value/Ebitda16.52
Forecast
1Y Price Target
$11.63Price Target Upside329.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe EPA approved Bioceres’ registration of Rinotec, expanding the technology into the US market, enhancing their position in the alternative pesticides market in the US and Brazil.
Regulatory ApprovalsBioceres has received regulatory approvals for its HB4 wheat and soybeans in multiple key agricultural countries, enhancing its market potential.
Technological AdvantageBioceres' HB4 GMO drought-resistant seed technology offers a competitive advantage by having no yield impact in varying precipitation conditions, unlike competing products.
Bears Say
Earnings DeclineThe decrease in adjusted EBITDA by approximately 57% year-over-year indicates pressure on Bioceres' profitability.
Financial PerformanceBioceres Crop Solutions reported revenues of $60.6M, down 28% year-over-year, and an adjusted EBITDA of $9M, down approximately 57% year-over-year.
Revenue DeclineBioceres Crop Solutions faced a significant drop in revenues, reflecting challenges in maintaining its financial growth trajectory.
Bioceres Crop Solutions News
BIOX FAQ
What was Bioceres Crop Solutions’s price range in the past 12 months?
Bioceres Crop Solutions lowest stock price was $2.60 and its highest was $10.19 in the past 12 months.
What is Bioceres Crop Solutions’s market cap?
Bioceres Crop Solutions’s market cap is $169.95M.
When is Bioceres Crop Solutions’s upcoming earnings report date?
Bioceres Crop Solutions’s upcoming earnings report date is Sep 09, 2025 which is in 2 days.
How were Bioceres Crop Solutions’s earnings last quarter?
Bioceres Crop Solutions released its earnings results on May 21, 2025. The company reported -$0.021 earnings per share for the quarter, beating the consensus estimate of -$0.125 by $0.104.
Is Bioceres Crop Solutions overvalued?
According to Wall Street analysts Bioceres Crop Solutions’s price is currently Undervalued.
Does Bioceres Crop Solutions pay dividends?
Bioceres Crop Solutions does not currently pay dividends.
What is Bioceres Crop Solutions’s EPS estimate?
Bioceres Crop Solutions’s EPS estimate is 0.07.
How many shares outstanding does Bioceres Crop Solutions have?
Bioceres Crop Solutions has 62,710,846 shares outstanding.
What happened to Bioceres Crop Solutions’s price movement after its last earnings report?
Bioceres Crop Solutions reported an EPS of -$0.021 in its last earnings report, beating expectations of -$0.125. Following the earnings report the stock price went down -4.301%.
Which hedge fund is a major shareholder of Bioceres Crop Solutions?
Currently, no hedge funds are holding shares in BIOX
Bioceres Crop Solutions Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.63 (329.15% Upside)
$11.63 (329.15% Upside)
Blogger Sentiment
Bullish
BIOX Sentiment 70%
Sector Average 74%
Sector Average 74%
Hedge Fund Trend
Increased
By 45.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.6%
Last 30 Days ▲ 11.4%
Last 30 Days ▲ 11.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-73.84%
12-Months-Change
Fundamentals
Return on Equity
-3.00%
Trailing 12-Months
Asset Growth
-4.53%
Trailing 12-Months
Company Description
Bioceres Crop Solutions
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
BIOX Company Deck
BIOX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance for Bioceres Crop Solutions. The company highlighted significant improvements in cash flow and the EPA approval of RinoTec, which positions them well for future opportunities. However, these positives were offset by a decline in revenues and gross profit due to seasonal factors and the absence of a major payment from Syngenta. Argentina's market challenges also weighed on performance, though positive developments in other geographies and segments offer a balanced outlook.View all BIOX earnings summariesBIOX Stock 12 Month Forecast
Average Price Target
$11.63
▲(329.15% Upside)
Technical Analysis
American Vanguard
―
Intrepid Potash
―
Scotts Miracle-Gro Company
―
Arcadia Biosciences
―
Lavoro Limited
―
Ownership Overview
―
Insiders
0.11% Mutual Funds
8.29% Other Institutional Investors
89.92% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---